Correspondence 0001193125-24-176845 from FIBROGEN INC (FGEN) (CIK 0000921299) (KYNB)
FIBROGEN INC (FGEN) (CIK 0000921299)
Date: July 9, 2024 · CIK: 0000921299 · Accession: 0001193125-24-176845
AI Filing Summary & Sentiment
File numbers found in text: 333-280597
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Attn: Daniel Crawford RE: FibroGen, Inc. Registration Statement on Form S-3 File No. 333-280597
Dear Mr. Crawford:
FibroGen, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on July 10, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes John T. McKenna of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with John T. McKenna of Cooley LLP, counsel to the Registrant, at (650) 843-5059.
Very truly yours,
FIBROGEN, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP VIA EDGAR July 9, 2024 United States Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Attn: Daniel Crawford RE: FibroGen, Inc. Registration Statement on Form S-3 File No. 333-280597 Dear Mr. Crawford: FibroGen, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on July 10, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes John T. McKenna of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with John T. McKenna of Cooley LLP, counsel to the Registrant, at (650) 843-5059. Very truly yours, FIBROGEN, INC. By: /S/ THANE WETTIG Name: Thane Wettig Title: Chief Executive Officer cc: Michael Lowenstein, FibroGen, Inc. John T. McKenna, Cooley LLP FibroGen, Inc. 409 Illinois Street San Francisco, California 94158